Search

everythinglearnresearchcommunity

for

Search:↓

Both treatments reduced androgen levels and hair growth in women with hirsutism.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Some men with early hair loss may have similar hormonal changes to women with Polycystic ovary syndrome, and could be at risk for developing type 2 diabetes.

Low-dose spironolactone is safe and effective for treating hirsutism.

Taking oral testosterone with or without dutasteride increases testosterone levels and could be an effective treatment for low testosterone.

The contraceptive reduced hair growth and altered hormone levels in hirsute women.

Excess male hormones in postmenopausal women can cause health issues and increase the risk of heart disease and diabetes; treatment depends on the cause.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

High triglyceride levels are a key factor affecting testosterone levels in women with PCOS.

Chinese women with PCOS have higher androgen levels, which change with age and weight.

The FG score is better at detecting hyperandrogenism in PCOS patients than testosterone levels or FAI, but testosterone is the recommended test for diagnosis.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

The treatment temporarily improved symptoms of hyperandrogenism in adolescents.

Early balding in men might be a male hormonal equivalent of polycystic ovaries syndrome in women.

Cyclosporine A therapy changes sex hormone levels differently in pre-menopausal and post-menopausal women with primary biliary cirrhosis.

Hormones significantly affect women's sexual function, and more research is needed to improve treatments for sexual dysfunction with minimal side effects.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

The review suggests a comprehensive approach to treat hirsutism, focusing on hair removal, medication, and managing emotional effects.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Men who went through puberty later had lower sperm counts and altered hormone levels, possibly affecting fertility.

Many women with polycystic ovary syndrome have normal blood sugar, but some may have higher blood sugar levels or diabetes, especially if they are older, overweight, and have certain hormone levels.

Androgen levels can increase at any age, affecting symptoms like acne, hair loss, and prostate size.

Clinical signs of hyperandrogenism are related to female pattern hair loss severity, but biochemical markers are not.

The Free Androgen Index (FAI) is the best indicator of early hair loss in men before age 30.

Birth control pills with low-dose estrogen and antiandrogenic progestins can effectively treat acne.

No significant hormone differences found in postmenopausal women with androgenetic alopecia.

A low-glycemic diet improved hormone levels and well-being in overweight women with high androgen levels.

Hormonal imbalances are important in the development of male pattern baldness.